LGT Group Foundation Reduces Stake in Colgate-Palmolive Company $CL

LGT Group Foundation lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 36.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 31,103 shares of the company’s stock after selling 17,961 shares during the period. LGT Group Foundation’s holdings in Colgate-Palmolive were worth $2,457,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CL. Tiemann Investment Advisors LLC increased its stake in Colgate-Palmolive by 2.1% in the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after purchasing an additional 125 shares during the last quarter. S.A. Mason LLC lifted its position in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock worth $280,000 after buying an additional 130 shares during the last quarter. Security National Bank of Sioux City Iowa IA lifted its position in shares of Colgate-Palmolive by 0.8% during the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock worth $1,298,000 after buying an additional 130 shares during the last quarter. Stratos Wealth Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after buying an additional 130 shares in the last quarter. Finally, Cordatus Wealth Management LLC grew its position in shares of Colgate-Palmolive by 0.6% in the 2nd quarter. Cordatus Wealth Management LLC now owns 23,036 shares of the company’s stock valued at $2,094,000 after buying an additional 134 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CL has been the subject of a number of research reports. Citigroup boosted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Wells Fargo & Company raised their price objective on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday, February 1st. UBS Group lifted their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Piper Sandler upped their target price on Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Stock Down 0.7%

Shares of NYSE:CL opened at $92.90 on Tuesday. The stock has a market cap of $74.88 billion, a P/E ratio of 35.46, a P/E/G ratio of 4.22 and a beta of 0.28. The firm has a fifty day moving average price of $89.24 and a 200 day moving average price of $83.08. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same period in the previous year, the business posted $0.91 earnings per share. Colgate-Palmolive’s quarterly revenue was up 5.8% on a year-over-year basis. Sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.2%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s payout ratio is 79.39%.

Insider Buying and Selling

In other news, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at $5,214,073.70. This trade represents a 63.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 184,683 shares of company stock valued at $17,486,693 in the last quarter. 0.41% of the stock is currently owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.